Search Results - "Pauly, Jeanne"

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia by Benjamin, Reuben, Graham, Charlotte, Yallop, Deborah, Jozwik, Agnieszka, Ciocarlie, Oana, Jain, Nitin, Jabbour, Elias J., Maus, Marcela V., Frigault, Matthiew, Boissel, Nicolas, Larghero, Jerome, Baruchel, Andre, Mohty, Mohamad, De Moerloose, Barbara, Bloor, Adrian, Frey, Noelle V., Zinaï, Amina, Balandraud, Svetlana, Philippe, Anne, Fouliard, Sylvain, Gauthier, Ludiane, Pauly, Jeanne, Konto, Cyril, Bermingham, Candy, Veys, Paul, Qasim, Waseem

“…Background UCART19 is an allogeneic, genetically modified CAR T-cell product (anti-CD19 scFv- 41BB-CD3ζ) manufactured from healthy donor T cells, in which TRAC…”
Get full text

Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia by Qasim, Waseem, Ciocarlie, Oana, Adams, Stuart, Inglott, Sarah, Murphy, Claire, Rivat, Christine, Wright, Gary, Lucchini, Giovanna, Silva, Juliana, Rao, Kanchan, Zinaï, Amina, Binlich, Florence, Dupouy, Sandra, Pauly, Jeanne, Balandraud, Svetlana, Dubois, Frédéric, Konto, Cyril, Patel, Premal, Chiesa, Robert, Samarasinghe, Sujith, Hara, Havinder, Boyle, Alayna, Chu, Jan, Pinner, Danielle, Amrolia, Persis J, Vora, Ajay, Rao, Anupama, Ancliffe, Philip, Veys, Paul

“…▪ Background UCART19 is a genetically modified T-cell product manufactured from non-HLA matched healthy donor cells and aims to provide a ready to use,…”
Get full text

Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with bevacizumab in patients with recurrent glioblastoma by Hoang-Xuan, Khe, Hottinger, Andreas, Royer-Perron, Louis, Alentorn, Agusti, Savatovsky, Julien, De Micheli, Rita, Homicsko, Krisztian, Banquet, Sebastien, Pauly, Jeanne, Sudey, Isabelle, Tell, Roger, Therasse, Patrick, Barrie, Maryline, Campello, Chantal, Chinot, Olivier L.

“…Abstract only…”
Get full text

Abstract C65: First-in-human Phase I dose-escalation study of a MET/AXL/FGFR inhibitor, S 49076, in patients with advanced solid tumors by Hollebecque, Antoine, Soria, Jean-Charles, Bahleda, Ratislav, Lopez-Busto, Natividad, Jacquet-Bescond, Anne, Burbridge, Mike F., Valérie, Cattan, Pauly, Jeanne, Herranz, Maria, Azaro, Analia, Depil, Stéphane, Rodon, Jordi

“…Abstract Background: S 49076 is a novel ATP-competitive tyrosine kinase inhibitor which displays a unique profile targeting MET, AXL and FGFR-1/2/3 (IC50 for…”
Get full text